Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 2, Pages e0118195
Publisher
Public Library of Science (PLoS)
Online
2015-02-13
DOI
10.1371/journal.pone.0118195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non–Small-Cell Lung Cancer after Neoadjuvant Chemotherapy
- (2013) William N. William et al. Journal of Thoracic Oncology
- Management of non-small-cell lung cancer: recent developments
- (2013) Martin Reck et al. LANCET
- DNA methylation: roles in mammalian development
- (2013) Zachary D. Smith et al. NATURE REVIEWS GENETICS
- Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions
- (2013) Dimo Dietrich et al. PLoS One
- Epigenetic Reprogramming in Cancer
- (2013) M. L. Suva et al. SCIENCE
- The role of DNA methylation as biomarkers in the clinical management of lung cancer
- (2013) Michael Fleischhacker et al. Expert Review of Respiratory Medicine
- Non-Small-Cell Lung Cancer: Treatment of Late Stage Disease: Chemotherapeutics and New Frontiers
- (2013) Ronald Scheff et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- A Paradigm Shift in the Treatment of Advanced Non-Small Cell Lung Cancer
- (2012) Shibu Varughese et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer
- (2012) J.-C. Soria et al. ANNALS OF ONCOLOGY
- DNA Methylation of the Homeobox Genes PITX2 and SHOX2 Predicts Outcome in Non–small-cell Lung Cancer Patients
- (2012) Dimo Dietrich et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Circulating Tumor Cells and Circulating Tumor DNA
- (2011) Catherine Alix-Panabières et al. Annual Review of Medicine
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
- (2010) Bernd Schmidt et al. BMC CANCER
- Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature
- (2010) Klaus Jung et al. CLINICA CHIMICA ACTA
- Epigenetics and gene expression
- (2010) E R Gibney et al. HEREDITY
- Maintenance and Consolidation Therapy in Patients with Unresectable Stage III/IV Non-Small Cell Lung Cancer
- (2010) N. Thatcher et al. ONCOLOGIST
- Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer
- (2008) S. Holdenrieder et al. CLINICAL CANCER RESEARCH
- Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer
- (2008) Stefan Holdenrieder et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now